🇪🇹 Country Profile

Ethiopia

Affordable medicine reaching Ethiopia

🇪🇹 $188M
All data from DGCIS India export records (fiscal year, April–March).
$188M
Scale
Ethiopia's healthcare system receives $188M in Indian pharmaceutical products each year, affordable, quality medicine.
71%
Medicine
Primarily medicines (71%), supplemented by vaccines and medicine ingredients.
1.9×
Trajectory
India's pharmaceutical supply to Ethiopia has grown 1.9× over the past decade, strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Africa.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Ethiopia, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $134M (71.3%) Vaccines $39.1M (20.8%) Medicine Ingredients $7.5M (4.0%) Surgical & Hospital Supplies $7.2M (3.9%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Ethiopia Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Ethiopia: $0.90M across 12 filings (2012-2015).